Published by Michele Maatouk on 17th June 2019
(Sharecast News) - Shares in cancer drug developer Array Biopharma rocketed on Monday after it agreed to be bought by Pfizer in a deal worth $11.4bn.
URL: http://www.digitallook.com/dl/news/story/29176774/...